Preoperative and Postoperative Sublingual Misoprostol for Prevention of Postpartum Blood Loss in Cesarean Section

Phase 4CompletedNCT03591913

Assiut University500 enrolled

Overview

Cesarean section is one of the most common major surgical operations among women. In 2015, the incidence of cesarean section in Woman Health Hospital in Assiut University accounts for 51.3 % of all deliveries

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

SINGLE

Enrollment

500

Conditions

Postpartum Hemorrhage

Interventions

MisoprostolDRUG

Oral tablets

Eligibility

Sex: FEMALE

Medical Language ↔ Plain English

Inclusion Criteria: * All pregnant women who will undergo elective lower segment cesarean section * term ( ≥ 37 weeks) * normal fetal heart tracing. Exclusion Criteria: * Placenta previa-Rupture uterus * Classical cesarean section * Preterm delivery * Hypertensive disorders of pregnancy * Bleeding tendency * Previous history of postpartum hemorrhage * Concurrent anticoagulant therapy * Concurrent long-term use of steroids * Fetal distress * Antepartum haemorrhage

Locations (1)

Ahmed Abbas

Assiut, Cairo Governorate, Egypt

Outcomes

Primary Outcomes

mean intraoperative blood loss

Blood loss estimation will commence immediately following the skin incision

Time frame: 24 hours

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.